TSX closed
Loading markets…
Stocks

Why VVT Med Inc. stock is skyrocketing today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:VVTM.V

Follow VVTM

Photos provided by Pexels

VVT Med Inc. has seen a remarkable surge in its stock price, gaining over 7% in just one trading day.

In the latest trading session, VVT Med Inc. (VVTM.V) experienced a significant increase of 7.14%, closing at CA$0.30. This uptick has caught the attention of investors, especially considering the company's recent advancements in medical technology.

VVT Med Inc.

VVTM.V

Full stock page →

VVTM.V

VVT Med Inc.

Source:WealthAwesomeWealthAwesome
↓ $0.14 (-48.28%)
120 day period
$0.15$0.23$0.32Feb 18Jun 24Nov 5

Market cap

$10.89M

52W high

$0.45

52W low

$0.15

1W change

-2.56%

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on VVTM's historical volatility

HistoricalForecast68%95%
C$0.03C$0.14C$0.24C$0.35C$0.46C$0.56TodayApr 30Jul 28Nov 5Dec 18Jan 31Mar 15

30-Day Vol

123.4%

Annualized

90-Day Vol

179.0%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.13

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.14C$0.09 – C$0.22
60 trading daysC$0.13C$0.07 – C$0.24
90 trading daysC$0.13C$0.06 – C$0.26

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: VVT Med Inc.'s recent performance reflects positive market sentiment, bolstered by its innovative medical solutions and successful patient treatments in Italy.

VVT Med Inc. up 7.14% in one day.

With a market cap of CA$20.1 million, VVT Med's stock performance indicates a growing interest in its innovative medical solutions amidst a competitive landscape.

Bull case

The successful treatment of the first patients with the ScleroSafe™ System in Italy shows VVT Med's potential to capture a growing market in medical technology. This suggests the possibility of future revenue growth and further stock appreciation.

Bear case

Despite the positive movement, VVT Med faces challenges like a management cease trade order and limited coverage, which could shake investor confidence and affect stock performance going forward.

Recent Developments Fueling Growth

VVT Med Inc. recently announced the successful treatment of the first patients using their ScleroSafe™ System in Italy. This breakthrough not only showcases the effectiveness of their technology but also positions the company favorably within the medical sector, potentially attracting more investors.

Market Reactions and Future Outlook

The stock's performance reflects a positive response from investors, likely driven by optimism surrounding VVT Med's innovative solutions. However, the company must navigate challenges such as the management cease trade order, which could affect investor sentiment in the long run. For more details on VVT Med's stock performance, visit our VVT Med Inc. stock page.

Understanding the Market Context

With a market cap of CA$20.1 million, VVT Med Inc. operates in a niche yet competitive market. Investors should consider both the potential for growth through innovative medical solutions and the inherent risks associated with small-cap stocks. For further insights, check out our comprehensive analysis on VVT Med Inc..


Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 13, 2026
Last Updated: October 3, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26